Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Richard

Showing results (561-570 of 578) with videos related to

Pageof 58
Sort By:
European Heart Journal|April 23, 2015
Current worldwide nuclear cardiology practices and radiation exposure: results from the 65 country IAEA Nuclear Cardiology Protocols Cross-Sectional Study (INCAPS)Andrew J Einstein, Thomas N B Pascual, Mathew Mercuri, et al.
JACC. Cardiovascular Imaging|January 17, 2021
Worldwide Variation in the Use of Nuclear Cardiology Camera Technology, Reconstruction Software, and Imaging ProtocolsCole B Hirschfeld, Mathew Mercuri, Thomas N B Pascual, et al.
Nature Communications|July 31, 2021
A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infectionTingting Li, Hongmin Cai, Hebang Yao, et al.
Nature Communications|July 27, 2022
Author Correction: A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infectionTingting Li, Hongmin Cai, Hebang Yao, et al.
EMBO Molecular Medicine|October 21, 2021
Uncovering a conserved vulnerability site in SARS-CoV-2 by a human antibodyTingting Li, Hongmin Cai, Yapei Zhao, et al.
Journal of Medicinal Chemistry|August 28, 2015
Synthesis and Pharmacological Characterization of C4-(Thiotriazolyl)-substituted-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylates. Identification of (1R,2S,4R,5R,6R)-2-Amino-4-(1H-1,2,4-triazol-3-ylsulfanyl)bicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY2812223), a Highly Potent, Functionally Selective mGlu2 Receptor AgonistJames A Monn, Lourdes Prieto, Lorena Taboada, et al.
Nature Genetics|May 1, 1997
Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomasL Schmidt, F M Duh, F Chen, et al.
British Journal of Cancer|May 20, 2004
Somatic mutations of KIT in familial testicular germ cell tumoursE A Rapley, S Hockley, W Warren, et al.
Nature Genetics|June 9, 2014
A reference genome for common bean and genome-wide analysis of dual domesticationsJeremy Schmutz, Phillip E McClean, Sujan Mamidi, et al.
Journal of Medicinal Chemistry|January 21, 2015
Synthesis and pharmacological characterization of C4-disubstituted analogs of 1S,2S,5R,6S-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylate: identification of a potent, selective metabotropic glutamate receptor agonist and determination of agonist-bound human mGlu2 and mGlu3 amino terminal domain structuresJames A Monn, Lourdes Prieto, Lorena Taboada, et al.
Pageof 58

Showing results (561-570 of 578) with videos related to

Sort By:
Pageof 58
European Heart Journal|April 23, 2015
Current worldwide nuclear cardiology practices and radiation exposure: results from the 65 country IAEA Nuclear Cardiology Protocols Cross-Sectional Study (INCAPS)Andrew J Einstein, Thomas N B Pascual, Mathew Mercuri, et al.
JACC. Cardiovascular Imaging|January 17, 2021
Worldwide Variation in the Use of Nuclear Cardiology Camera Technology, Reconstruction Software, and Imaging ProtocolsCole B Hirschfeld, Mathew Mercuri, Thomas N B Pascual, et al.
Nature Communications|July 31, 2021
A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infectionTingting Li, Hongmin Cai, Hebang Yao, et al.
Nature Communications|July 27, 2022
Author Correction: A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infectionTingting Li, Hongmin Cai, Hebang Yao, et al.
EMBO Molecular Medicine|October 21, 2021
Uncovering a conserved vulnerability site in SARS-CoV-2 by a human antibodyTingting Li, Hongmin Cai, Yapei Zhao, et al.
Journal of Medicinal Chemistry|August 28, 2015
Synthesis and Pharmacological Characterization of C4-(Thiotriazolyl)-substituted-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylates. Identification of (1R,2S,4R,5R,6R)-2-Amino-4-(1H-1,2,4-triazol-3-ylsulfanyl)bicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY2812223), a Highly Potent, Functionally Selective mGlu2 Receptor AgonistJames A Monn, Lourdes Prieto, Lorena Taboada, et al.
Nature Genetics|May 1, 1997
Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomasL Schmidt, F M Duh, F Chen, et al.
British Journal of Cancer|May 20, 2004
Somatic mutations of KIT in familial testicular germ cell tumoursE A Rapley, S Hockley, W Warren, et al.
Nature Genetics|June 9, 2014
A reference genome for common bean and genome-wide analysis of dual domesticationsJeremy Schmutz, Phillip E McClean, Sujan Mamidi, et al.
Journal of Medicinal Chemistry|January 21, 2015
Synthesis and pharmacological characterization of C4-disubstituted analogs of 1S,2S,5R,6S-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylate: identification of a potent, selective metabotropic glutamate receptor agonist and determination of agonist-bound human mGlu2 and mGlu3 amino terminal domain structuresJames A Monn, Lourdes Prieto, Lorena Taboada, et al.
Pageof 58